The conclusion seems to be that investors are not being paid well at present to take the incremental risk of high yield bonds over Treasuries.

FORBES: Is Emerging Markets Debt Cheap?

She said: "If the clinicians in the case are saying it could have an impact, it seems absurd to give him a drug when he could be at risk".

BBC: NHS Lucentis drug refusal could 'leave man blind'

The problem here seems to be not that users are put at any kind of serious risk, but that the release of their data technically violates the law.

FORBES: Could Netflix Prize 2 turn into a horror film?